Drugs Controller General of India
-
Drug regulators stop production at 18 firms in drive against spurious medicines
Scroll Staff
-
DGCI issues notices to Amazon, Flipkart for selling drugs without licence
Scroll Staff
-
WHO drew premature link between deaths of children in Gambia and India-made cough syrups, says DCGI
Scroll Staff
-
Covid-19: Bharat Biotech’s intranasal vaccine gets emergency use approval
Scroll Staff
-
Covid-19: Covovax gets expert panel nod for use among children aged between 7 and 11 in India
Scroll Staff
-
Bharat Biotech gets approval to conduct trials for its intranasal Covid-19 booster dose
Scroll Staff
-
Covid-19: Expert panel on vaccines recommends regular market approval for Covishield, Covaxin
Scroll Staff
-
Covid-19: Hetero gets approval for emergency use of Tocilizumab drug
Scroll Staff
-
Coronavirus: DCGI has approved oral drug for emergency use, says DRDO
Scroll Staff
-
Zydus Cadila seeks DCGI approval for using its hepatitis drug for treatment of coronavirus
Scroll Staff
-
Covid-19 vaccine: Dr Reddy’s begins process of Sputnik V’s emergency use approval in India
Scroll Staff
-
Serum Institute seeks approval to conduct India trial for Novavax’s Covid vaccine, says Poonawalla
Scroll Staff
-
Coronavirus: India approves vaccines by Serum Institute, Bharat Biotech for restricted emergency use
Scroll Staff
-
Coronavirus: Dr Reddy’s gets drugs regulator approval to test Russia’s Sputnik-V vaccine
Scroll Staff
-
Coronavirus: Vaccine candidate should have at least 50% efficacy in Phase-3 trials, says DGCI
Scroll Staff
-
Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine
Scroll Staff
-
Coronavirus: Drugs regulator sends notice to Serum Institute of India for not halting vaccine trials
Scroll Staff
-
Few inspectors, no records: Drug regulation in India is hobbled by a number of problems
Swagata Yadavar, IndiaSpend.com